Literature for peptidase S01.087: TMPRSS13 peptidase
(Topics flags: R Splicing, K Knockout, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Joushomme,A., Desilets,A., Champagne,W., Hassanzadeh,M., Lemieux,G., Gravel-Trudeau,A., Lepage,M., Lafreniere,S., Froehlich,U., List,K., Boudreault,P.L. and Leduc,R.
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
J Enzyme Inhib Med Chem (2025) 40, 2466841-2466841. PubMed Europe PubMed DOI PMC EPMC I -
Vegh,B., Kocsis,A., Dobo,J., Balczer,J., Kiss,B., Pal,G. and Gal,P.
Efficient production of fully active, SARS-CoV-2-priming, wildtype TMPRSS2 ectodomain via co-expression of HAI-2 allows for both auto- and cross-activation mechanisms
Biochem J (2025) 482, 1993-2010. PubMed Europe PubMed DOI -
Han,Y., Ma,Y., Wang,Z., Feng,F., Zhou,L., Feng,H., Ma,J., Ye,R. and Zhang,R.
TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus
J Med Virol (2024) 96, e29712-e29712. PubMed Europe PubMed DOI -
Jin,Z., Zhang,Y., Chen,W., Li,H., Shi,L., Wang,D., Zhu,R. and Zhang,C.
Intracellular autoactivation and surface location of hepsin, TMPRSS2, and TMPRSS13
Life Sci (2024) , 123299-123299. PubMed Europe PubMed DOI -
Martin,C.E., Murray,A.S., Mackinder,J.R., Sala-Hamrick,K.E., Flynn,M.G., Lundgren,J.G., Varela,F.A. and List,K.
TMPRSS13 zymogen activation, surface localization, and shedding is regulated by proteolytic cleavage within the non-catalytic stem region
Biol Chem (2022) 403, 969-982. PubMed Europe PubMed DOI -
Martin,C.E., Murray,A.S., Sala-Hamrick,K.E., Mackinder,J.R., Harrison,E.C., Lundgren,J.G., Varela,F.A. and List,K.
Posttranslational modifications of serine protease TMPRSS13 regulate zymogen activation, proteolytic activity, and cell surface localization
J Biol Chem (2021) 297, 101227-101227. PubMed Europe PubMed DOI PMC EPMC -
Murray,A.S., Hyland,T.E., Sala-Hamrick,K.E., Mackinder,J.R., Martin,C.E., Tanabe,L.M., Varela,F.A. and List,K.
The cell-surface anchored serine protease TMPRSS13 promotes breast cancer progression and resistance to chemotherapy
Oncogene (2020) PubMed Europe PubMed DOI K -
Madsen,D.H., Szabo,R., Molinolo,A.A. and Bugge,T.H.
TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition
Biochem J (2014) 461, 487-495. PubMed Europe PubMed DOI K -
Zmora,P., Blazejewska,P., Moldenhauer,A.S., Welsch,K., Nehlmeier,I., Wu,Q., Schneider,H., Pohlmann,S. and Bertram,S.
DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry
J Virol (2014) 88, 12087-12097. PubMed Europe PubMed DOI -
Antalis,T.M., Bugge,T.H. and Wu,Q.
Membrane-anchored serine proteases in health and disease
Prog Mol Biol Transl Sci (2011) 99, 1-50. PubMed Europe PubMed DOI V -
Hashimoto,T., Kato,M., Shimomura,T. and Kitamura,N.
TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor
FEBS J (2010) 277, 4888-4900. PubMed Europe PubMed DOI -
Okumura,Y., Takahashi,E., Yano,M., Ohuchi,M., Daidoji,T., Nakaya,T., Bottcher,E., Garten,W., Klenk,H.D. and Kido,H.
Novel type II transmembrane serine proteases, MSPL and TMPRSS13, proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication
J Virol (2010) 84, 5089-5096. PubMed Europe PubMed DOI R -
Kido,H. and Okumura,Y.
Mspl/Tmprss13
Front Biosci (2008) 13, 754-758. PubMed Europe PubMed DOI V -
Szabo,R., Wu,Q., Dickson,R.B., Netzel-Arnett,S., Antalis,T.M. and Bugge,T.H.
Type II transmembrane serine proteases
Thromb Haemost (2003) 90, 185-193. PubMed Europe PubMed DOI V -
[YEAR:19-3-2001]Kim,D.R., Sharmin,S., Inoue,M. and Kido,H.
Cloning and expression of novel mosaic serine proteases with and without a transmembrane domain from human lung
Biochim Biophys Acta (19-3-2001) 1518, 204-209. PubMed Europe PubMed DOI
2025
2024
2022
2021
2020
2014
2011
2010
2008
2003
2001
